PASINI, AUGUSTO
 Distribuzione geografica
Continente #
NA - Nord America 35.249
EU - Europa 2.921
AS - Asia 2.816
SA - Sud America 442
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 41
OC - Oceania 10
Totale 41.633
Nazione #
US - Stati Uniti d'America 35.108
SG - Singapore 1.232
CN - Cina 659
DE - Germania 479
UA - Ucraina 460
IT - Italia 359
RU - Federazione Russa 346
BR - Brasile 341
IE - Irlanda 275
SE - Svezia 241
VN - Vietnam 240
HK - Hong Kong 237
GB - Regno Unito 210
FR - Francia 184
FI - Finlandia 112
PL - Polonia 110
KR - Corea 92
JP - Giappone 76
CA - Canada 66
BD - Bangladesh 59
IN - India 54
MX - Messico 38
TW - Taiwan 33
AR - Argentina 28
BE - Belgio 26
NL - Olanda 26
TR - Turchia 24
CZ - Repubblica Ceca 23
CO - Colombia 20
EC - Ecuador 19
ES - Italia 19
IQ - Iraq 15
CL - Cile 14
ID - Indonesia 14
AT - Austria 13
EU - Europa 13
IL - Israele 12
MY - Malesia 12
ZA - Sudafrica 12
CH - Svizzera 9
AU - Australia 8
PK - Pakistan 8
CR - Costa Rica 7
PH - Filippine 7
PY - Paraguay 7
IR - Iran 6
VE - Venezuela 6
EG - Egitto 5
JM - Giamaica 5
KE - Kenya 5
MA - Marocco 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LT - Lituania 4
SA - Arabia Saudita 4
TH - Thailandia 4
UY - Uruguay 4
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
LV - Lettonia 1
MN - Mongolia 1
OM - Oman 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
Totale 41.490
Città #
Woodbridge 10.278
Wilmington 8.514
Houston 7.743
Fairfield 924
Ann Arbor 899
Ashburn 758
Singapore 740
Chandler 570
Jacksonville 422
San Jose 398
Seattle 381
Cambridge 321
Beijing 272
Dublin 269
Hong Kong 235
Medford 203
New York 180
Dearborn 179
Council Bluffs 162
Santa Clara 130
The Dalles 113
Lawrence 99
Los Angeles 86
Ho Chi Minh City 83
Kraków 75
Rome 67
Dallas 65
Tokyo 64
Mülheim 63
Buffalo 52
Menlo Park 50
San Diego 50
Hanoi 48
Milan 47
Moscow 46
Redwood City 46
Lauterbourg 44
Boardman 42
Munich 38
Zhengzhou 37
São Paulo 36
Falls Church 35
Phoenix 34
Taipei 32
Norwalk 30
Brooklyn 26
Palo Alto 26
Mountain View 25
Brno 23
Brussels 23
North Bergen 23
San Mateo 22
Chicago 21
London 21
Nanjing 21
Atlanta 20
Toronto 20
Columbus 19
Washington 19
Orem 18
Redondo Beach 18
University Park 17
Frankfurt am Main 16
Guangzhou 16
Kunming 16
Rio de Janeiro 16
Warsaw 15
Brasília 14
Chennai 14
Denver 14
Montreal 14
San Francisco 14
Istanbul 13
Miami 13
Detroit 12
Hefei 12
Nuremberg 12
Stockholm 12
Verona 12
Helsinki 11
Las Vegas 11
Nanchang 11
Catania 10
Da Nang 10
Guayaquil 10
Amsterdam 9
Poplar 9
Turku 9
Belo Horizonte 8
Bogotá 8
Boston 8
Haiphong 8
Manchester 8
Mexico City 8
Nürnberg 8
Porto Alegre 8
Shanghai 8
Bytom 7
Campinas 7
Curitiba 7
Totale 35.740
Nome #
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment 578
Alexithymia as related to sex, age, and educational level: Results of the Toronto Alexithymia Scale in 417 normal subjects 556
Association study of a promoter polymorphism of UFD1L gene with schizophrenia 540
Association between schizohprenia and UFD1L. A developmental gene mapped to chromosome 22 533
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients 505
Asynchronicity of Organic and Psychiatric Symptoms in a Case of Sertraline Intoxication 502
Human endogenous retroviruses and ADHD 501
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study 497
Assessing attentional systems in children with Attention Deficit Hyperactivity Disorder 496
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients. 493
5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo 493
Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings 484
Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia 483
Detecting anxiety symptoms in children and youths with neurofibromatosis type I 482
Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy 481
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case-control study 480
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 479
Fluoxetine alone in the treatment of first episode anxious-depression: An open clinical trial 478
Adhd and human endogenous retroviruses 478
Fluoxetine decreases concentrations of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression 477
Residential facilities for older people in Italy: a five-region survey 477
Patients with deficit, nondeficit, and negative symptom schizophrenia: Do they differ during episodes of acute psychotic decompensation? 476
Neuroleptic treatments and overflow movements in schizophrenia: are they independent? 475
Effects of antidepressant treatment on neuroactive steroids in major depression 471
Alexithymic features in stroke: Effects of laterality and gender 463
Typical and atypical antipsychotic use in aggressive children and adolescents: A systematic review [Uso degli antipsicotici tipici e atipici nel trattamento dell'aggressività nell'infanzia e nell'adolescenza: Revisione sistematica della letteratura] 462
ALEXITHYMIA AS RELATED TO SEX, AGE, AND EDUCATIONAL-LEVEL - RESULTS OF THE TORONTO ALEXITHYMIA SCALE IN 417 NORMAL SUBJECTS 458
Impairment in flexible regulation of speed and accuracy in children with ADHD 455
Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. 453
Change blindness in children with ADHD: a selective impairment in visual search? 453
Neuroactive steroids in responders and nonresponders to sleep deprivation 452
Overflow movements and white matter abnormalities in ADHD 451
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 451
Neurosteroids as neuromodulators in the treatment of anxiety disorders 449
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 447
Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy 445
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia 444
Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention 444
Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression 442
Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder preliminary results 441
Overflow movements and white matter abnormalities in ADHD 439
Increased neurosteroids synthesis after brain and spinal cord injury in rats 438
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers 438
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3 alpha-hydroxysteroid dehydrogenase activity 437
The neurobiology of attention deficit/hyperactivity disorder. 436
Attention and executive functions profile in drug naive ADHD subtypes 434
Psychiatric symptoms in male cannabis users not using other illicit drugs 434
Pathophysiology of NSS in ADHD 433
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery 429
Anticonvulsant effect of intranigral fluoxetine 429
Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder 428
Controlling attention to gaze and arrows in attention deficit hyperactivity disorder 427
Marked decrease of plasma neuroactive steroids during alcohol withdrawa 426
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 426
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 424
Ethological predictors of amitriptyline response in depressed outpatients 424
Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities 419
Impaired reflexive orienting to social cues in attention deficit hyperactivity disorder 415
Inhibition of return in response to eye gaze and peripheral cues in young people with Asperger's syndrome 414
Altered anandamide degradation in attention-deficit/hyperactivity disorder 412
A Small Supernumerary Marker Derived from the Pericentromeric Region of Chromosome 5: Case Report and Delineation of Partial Trisomy 5p Phenotype 411
Reduced prefrontal cognitive activation associated with aggression in schizophrenia 409
Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3 alpha, 5 alpha tetrahydrodeoxycorticosterone (3 alpha, 5 alpha-THDOC) in healthy volunteers 408
The complex roles of neurosteroids in depression and anxiety disorders. 408
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 402
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. 402
Neurological soft signs, but not theory of mind and emotion recognition deficit distinguished children with ADHD from healthy control 402
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients 401
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients 400
Nonverbal behavior and alexithymic traits in normal subjects. Individual differences in encoding emotions 399
Fluoxetine and seizures 395
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders 394
Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers [1] 393
Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms 392
Motor examination in children with Attention-deficit/hyperactivity Disorder and Asperger Syndrome 391
Neurosteroids in developmental disorders 385
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome 385
Is it confirmed the presence of neurological soft signs in children with Neurofibromatosis type 1? 383
Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations 379
Pathophysiology of NSS in ADHD 378
Comorbidity of ADHD and High-functioning Autism: A Pilot Study on the Utility of the Overflow Movements Measure 378
Visual search and emotion: how children with autism spectrum disorders scan emotional scenes 375
Ethological assessment of the DSM-III subtyping of unipolar depression 372
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD 372
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin 366
Neuroactive steroids as modulators of depression and anxiety 365
[Executive function deficits in ADHD and Asperger syndrome] 365
Explicit incestuous motifs and emotional crises in psychosomatic patients 363
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin 362
Influence of sleep deprivation major depression on neuroactive steroids in major depression 343
LE ALLUCINAZIONI 343
Non-verbal behaviour deficits in schizophrenia: an ethological study of drug-free patients 323
Il Delirio 308
I retrovirus endogeni nella sindrome da deficit di attenzione e iperattività (ADHD). 304
Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders 272
The decrease in human endogenous retrovirus-H activity runs in parallel with improvement in ADHD symptoms in patients undergoing methylphenidate therapy 266
Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: A pilot study 187
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 172
Rett syndrome in males: The different clinical course in two brothers with the same microduplication MECP2 Xq28 122
The Effects of Lock-down 2020 on the Behaviour and Mood of Children Aged Three to Six in Italy 71
Totale 41.633
Categoria #
all - tutte 89.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022812 0 0 0 64 25 124 43 53 76 95 62 270
2022/20231.453 127 91 36 217 144 338 116 98 128 2 125 31
2023/2024510 62 27 43 11 45 176 49 6 4 8 7 72
2024/20251.791 100 458 262 122 50 83 87 110 162 127 132 98
2025/20263.375 359 162 395 265 349 105 351 426 439 293 120 111
2026/20271.404 136 203 745 320 0 0 0 0 0 0 0 0
Totale 41.633